The learning objectives are here:

1.    Evaluate the evidence supporting axillary de-escalation and the factors that predict treatment response 
2.    recognize patterns of discordant response between the breast and axilla
3.    examine whether residual disease represents a biologically distinct, treatment-resistant population 
4.    consider how metabolic and microenvironment profiling could inform future prognostic and therapeutic strategies